TSE:4569Pharmaceuticals
KYORIN Pharmaceutical (TSE:4569) Stock Faces Margin Squeeze At 30.2x P E
KYORIN Pharmaceutical stock has been grinding lower for months, with the price down roughly 25% over 90 days, yet today’s Q1 2027 earnings land with a very different message. The headline is margin strain. Net profit margin over the last year sits at about 1.7%, well below the 7.8% level seen a year ago, even as earnings per share over the trailing twelve months total ¥37.81.
For investors, this earnings print is less about revenue size and more about what the shrinking margin and a rich P/E...